Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Sonnet BioTherapeutics Holdings, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
Who is behind it
Sonnet BioTherapeutics Holdings, Inc.: incorporated in Delaware; business address in Princeton, New Jersey; industry Pharmaceutical Preparations (Form 8-K, 2025-12-03).
Officers and directors, each with the role and the filing that names them:
- Pankaj Mohan: Executive Officer, Director (Form D, 2024-12-23)
- Jay Cross: Executive Officer (Form D, 2024-12-23)
- John K. Cini: Executive Officer (Form D, 2024-12-23)
- Susan Dexter: Executive Officer (Form D, 2024-12-23)
- Richard Kenny: Executive Officer (Form D, 2024-12-23)
- Nailesh Bhatt: Director (Form D, 2024-12-23)
- Albert Dyrness: Director (Form D, 2024-12-23)
- Donald Griffith: Director (Form D, 2024-12-23)
- Raghu Rao: Director (Form D, 2024-12-23)
- Lori McNeil: Director (Form D, 2024-12-23)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2025-07-25 | Republic Digital Opportunistic Digital Assets Master Fund, LTD. | 4.2% |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2024-12-23 | $3.92M | $3.92M |
| Form D, 2023-07-17 | $2.25M | $2.25M |
Latest IPO step: Sonnet BioTherapeutics Holdings, Inc. amended its IPO registration (S-1/A, 2025-01-30).
IPO filings: S-1/A, 2025-01-30, S-1/A, 2025-01-30, S-1, 2025-01-22, S-1, 2025-01-22, 424B4, 2024-11-07; ticker SONN on Nasdaq Capital Market.
Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2025-12-03).
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/sonnet-biotherapeutics